Skip to main content
fghjkjhb

Evidence gap analysis

Strategic analysis of the sufficiency of evidence to obtain reimbursement and HTA approval in Europe and recommendations about evidence generation

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

2025 European MedTech Market Access Playbook Released

MTRC is pleased to present the 2025 European MedTech Market Access Playbook - your annual, refresh‑and‑reuse roadmap to every EU reimbursement deadline.

Because the major reimbursement milestones repeat on the same cadence year after year, this calendar is designed as an annual reference you can refresh and reuse for every coming season.

  • Crystal‑clear hard deadlines. We list only the milestones that follow fixed schedules, so you’ll never miss a cut‑off—this year or next.
  • Flexible windows flagged. When authorities give a date range instead of a day, we mark it as “flexible,” letting you allocate resources with confidence.
  • Ready for the long haul. Each edition drops at the start of the year, but its structure stays constant, making it easy to roll forward and keep your launch plans on track well beyond 2025.

Pin it, share it, and keep it on hand: your annual shortcut to flawless market access execution.

Request a Pocket Brief and advance your understanding of European market access for medical devices.